Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Autoantigens HELP
Based on 7,707 articles published since 2010
||||

These are the 7707 published articles about Autoantigens that originated from Worldwide during 2010-2020.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline [Pemphigoid gestationis. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. 2011

Ingen-Housz-Oro, S / Bedane, C / Prost, C / Joly, P / Bernard, P / Anonymous430689. ·Service de dermatologie, hôpital Henri-Mondor, 51 avenue du Maréchal-de-Lattre-de-Tassigny, Créteil, France. saskia.oro@hmn.aphp.fr ·Ann Dermatol Venereol · Pubmed #21397157.

ABSTRACT: -- No abstract --

2 Guideline [Mucous membrane pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. 2011

Bedane, C / Prost, C / Ingen-Housz-Oro, S / Joly, P / Bernard, P / Anonymous420689. ·Service de dermatologie, hôpital Dupuytren, université de Limoges, 2 avenue Martin-Luther-King, Limoges cedex, France. christophe.bedane@chu-limoges.fr ·Ann Dermatol Venereol · Pubmed #21397156.

ABSTRACT: -- No abstract --

3 Guideline [Pemphigus. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. 2011

Joly, P / Bernard, P / Bedane, C / Prost, C / Ingen-Housz-Oro, S / Anonymous410689. ·Clinique dermatologique, hôpital Charles-Nicolle, université de Rouen, 1 rue Germont, Rouen cedex, France. Pascal.Joly@chu-rouen.fr ·Ann Dermatol Venereol · Pubmed #21397155.

ABSTRACT: -- No abstract --

4 Guideline [Bullous pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. 2011

Bernard, P / Bedane, C / Prost, C / Ingen-Housz-Oro, S / Joly, P / Anonymous400689. ·Service de dermatologie, CHU de Reims, université de Reims, 45 rue Cognacq-Jay, Reims, France. pbernard@chu-reims.fr ·Ann Dermatol Venereol · Pubmed #21397154.

ABSTRACT: -- No abstract --

5 Editorial OMG: MS, NMOSD, and MOG. 2019

Lewis, Steven L. ·EDITOR-IN-CHIEF. ·Continuum (Minneap Minn) · Pubmed #31162306.

ABSTRACT: -- No abstract --

6 Editorial Live-cell based assays are the gold standard for anti-MOG-Ab testing. 2019

Yeh, E Ann / Nakashima, Ichiro. ·From the Division of Neurology (E.A.Y.), Department of Pediatrics, Division of Neuroscience and Mental Health, SickKids Research Institute, The Hospital for Sick Children, and University of Toronto, Ontario, Canada · and Department of Neurology (I.N.), Tohoku Medical and Pharmaceutical University, Sendai, Japan. ·Neurology · Pubmed #30728306.

ABSTRACT: -- No abstract --

7 Editorial Cambridge Ophthalmological Symposium 2018: introduction and reflections on the day. 2019

Ludgate, Marian. ·Professor Emerita, Institute of Infection & Immunity, School of Medicine, Cardiff, UK. Ludgate@cardiff.ac.uk. ·Eye (Lond) · Pubmed #30568255.

ABSTRACT: I was privileged to be one of the co-chairs, along with Professor Tim Sullivan (Brisbane, Australia), for the Cambridge Ophthalmological Society (COS) annual international symposium, which, this year, was dedicated to thyroid eye disease (TED). Together with the organisers, Miss Rachna Murthy and Professor Keith Martin from COS, we compiled an impressive programme covering all aspects of the condition from events happening in a single orbital cell to improved surgical approaches.

8 Editorial What structures are seen by a T cell in the immune response to a lupus autoantigen? 2019

Winchester, Robert. ·Autoimmune and Molecular Diseases, Columbia University, New York City, NY 10032, USA rjw8@columbia.edu. ·Ann Rheum Dis · Pubmed #30352889.

ABSTRACT: -- No abstract --

9 Editorial Editorial - NETs in autoimmune diseases. 2018

Boeltz, Sebastian / Herrmann, Martin. ·a Department of Internal Medicine 3, Rheumatology and Immunology , Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen , Erlangen , Germany. ·Autoimmunity · Pubmed #30994384.

ABSTRACT: -- No abstract --

10 Editorial Peroxidasin-a Novel Autoantigen in Anti-GBM Disease? 2018

McAdoo, Stephen P / Pusey, Charles D. ·Centre for Inflammatory Disease, Department of Medicine, Imperial College London, London, United Kingdom s.mcadoo@imperial.ac.uk. · Centre for Inflammatory Disease, Department of Medicine, Imperial College London, London, United Kingdom. ·J Am Soc Nephrol · Pubmed #30314979.

ABSTRACT: -- No abstract --

11 Editorial Celiac Disease Autoimmunity. 2018

López Casado, Miguel Ángel / Lorite, Pedro / Ponce de León, Candelaria / Palomeque, Teresa / Torres, Maria Isabel. ·Department of Pediatrics Gastroenterology, Hospital Virgen de las Nieves, Granada, Spain. · Department of Experimental Biology, University of Jaén, Jaén, Spain. · Department of Experimental Biology, University of Jaén, Jaén, Spain. mitorres@ujaen.es. ·Arch Immunol Ther Exp (Warsz) · Pubmed #30167716.

ABSTRACT: Celiac disease is an autoimmune condition triggered by the ingestion of gluten, the protein fraction of wheat, barley and rye. It is not simply an intestinal disease; it is multifactorial caused by many different genetic factors acting together with non-genetic causes. Similar to other autoimmune diseases, celiac disease is a polygenic disorder for which the major histocompatibility complex locus is the most important genetic factor, and is the result of an immune response to self-antigens leading to tissue destruction and the autoantibodies production. Celiac disease exemplifies how an illness can have autoimmune-like features having to be driven by exogenous antigen and how can be reasonably considered as a model of organ-specific autoimmunity.

12 Editorial MOG antibody disorders and AQP4 antibody NMO spectrum disorders share a common immunopathogenesis. 2018

Uzawa, Akiyuki / Mori, Masahiro / Kuwabara, Satoshi. ·Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. ·J Neurol Neurosurg Psychiatry · Pubmed #29875185.

ABSTRACT: -- No abstract --

13 Editorial Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder. 2018

Hacohen, Yael / Palace, Jacqueline. ·From the Department of Neuroinflammation (Y.H.), Queen Square MS Centre, UCL Institute of Neurology · Department of Paediatric Neurology (Y.H.), Great Ormond Street Hospital for Children, London · and Neurology Department (J.P.), John Radcliffe Hospital, Oxford, UK. ·Neurology · Pubmed #29695599.

ABSTRACT: -- No abstract --

14 Editorial Graft-derived exosomes. When small vesicles play a big role in transplant rejection. 2018

Benichou, Gilles / Prunevieille, Aurore. ·Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. ·Am J Transplant · Pubmed #29505692.

ABSTRACT: -- No abstract --

15 Editorial Clinical course of MOG antibody-associated recurrent demyelinating diseases. 2018

Reindl, Markus. · ·J Neurol Neurosurg Psychiatry · Pubmed #29175896.

ABSTRACT: -- No abstract --

16 Editorial MOG Antibodies in Pediatric Neurology. 2018

Huppke, Peter. ·Department of Pediatrics and Pediatric Neurology, University Medical Center Göttingen, Georg August University, Göttingen, Germany. ·Neuropediatrics · Pubmed #28915516.

ABSTRACT: -- No abstract --

17 Editorial Anti-MOG syndrome: a road to be paved. 2017

Adoni, Tarso. ·Hospital Sírio-Libanês, São Paulo SP, Brasil. · Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Departamento de Neurologia, São Paulo SP, Brasil. ·Arq Neuropsiquiatr · Pubmed #29166457.

ABSTRACT: -- No abstract --

18 Editorial An Emerging Role for Megalin as a Regulator of Protein Leak in Acute Lung Injury. 2017

Suber, Tomeka / Mallampalli, Rama K. ·1 Department of Medicine University of Pittsburgh Pittsburgh, Pennsylvania and. · 2 Medical Specialty Service Line Veterans Affairs Pittsburgh Healthcare System Pittsburgh, Pennsylvania. ·Am J Respir Cell Mol Biol · Pubmed #29090957.

ABSTRACT: -- No abstract --

19 Editorial A bridge between evidence-based laboratory diagnostics and research in neuroimmunology: why standardizations and guidelines matter. 2017

Franciotta, Diego / Uccelli, Antonio / Anonymous4160923. ·Laboratory of Neuroimmunology, IRCCS, C. Mondino National Neurological Institute, I-27100, Pavia, Italy. diego.franciotta@mondino.it. · Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health Unit, University of Genoa, Genoa, Italy. · IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy. · Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy. ·Neurol Sci · Pubmed #29030771.

ABSTRACT: -- No abstract --

20 Editorial Is MOG-IgG another biomarker for neuromyelitis optica? 2017

Nakashima, Ichiro. · ·J Neurol Neurosurg Psychiatry · Pubmed #28684533.

ABSTRACT: -- No abstract --

21 Editorial Regulatory T cells, as a target in anticancer immunotherapy. 2017

Enokida, Tomohiro / Nishikawa, Hiroyoshi. ·Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba 277-8577, Japan. · Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan. ·Immunotherapy · Pubmed #28653572.

ABSTRACT: -- No abstract --

22 Editorial Is Tolerance Broken in Autoimmunity? 2017

Laxminarayana, Dama. ·Editor in Chief, Clinical Medicine Insights: Pathology; Sathya Krishna Genomics LLC, Winston-Salem, NC, USA. ·Clin Med Insights Pathol · Pubmed #28579863.

ABSTRACT: Autoimmune diseases are classified into about 80 different types based on their specificity related to system, organ and/or tissue. About 5% of the western population is affected by this anomaly, but its worldwide incidence is unknown. Autoimmune diseases are heterogeneous in nature and clinical manifestations range from benign disorders to life-threatening conditions. Autoimmunity strikes at any stage of life, but age and/or gender also play role in onset of some of these anomalies. The autoimmune pathogenesis is initiated by the origination of autoantigens, which leads to the development of autoantibodies followed by auto-immunogenicity and the ultimate onset of autoimmunity. There is a lack of suitable therapies to treat autoimmune diseases, because mechanisms involved in the onset of these anomalies were poorly understood. Present therapies are limited to symptomatic treatment and come with severe side effects. Here, I described the molecular mechanisms and cellular events involved in the initiation of autoimmunity and proposed better strategies to modulate such molecular and cellular anomalies, which will help in preventing and/or controlling autoimmune pathogenesis and ultimately aid in enhancing the quality of life.

23 Editorial G 2017

Waters, Patrick J / Irani, Sarosh R. ·From the University of Oxford, UK. paddy.waters@ndcn.ox.ac.uk. · From the University of Oxford, UK. ·Neurology · Pubmed #28202698.

ABSTRACT: -- No abstract --

24 Editorial The autoimmune tautology. A summary of evidence. 2017

Anaya, Juan-Manuel. ·Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24-63-C-69, Bogota, Colombia. Electronic address: juan.anaya@urosario.edu.co. ·Joint Bone Spine · Pubmed #28017820.

ABSTRACT: -- No abstract --

25 Editorial Moving towards a new class of vaccines for non-infectious chronic diseases. 2016

Chackerian, Bryce / Frietze, Kathryn M. ·a Department of Molecular Genetics and Microbiology , University of New Mexico , Albuquerque , NM , USA. ·Expert Rev Vaccines · Pubmed #26919571.

ABSTRACT: -- No abstract --

Next